Ying Cao

发表

Effects of hemocoagulase agkistrodon on the coagulation factors and its procoagulant activities

Haixin Li, Qimei Wang, Ying Huang, 2018, Drug design, development and therapy.

Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)

Jiasheng Chen, Haixin Li, Ting Wu, 2017, Pharmacological reports : PR.

Identification and characterization of a potent and selective inhibitor of human urate transporter 1

Jiasheng Chen, Haixin Li, Yuan-xin Tian, 2017, Pharmacological Reports.

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia

Yong-mei Li, P. Zhou, Yuan-xin Tian, 2021, Acta Pharmacologica Sinica.

Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents.

Zhipeng Chen, K. Cheng, Ying Cao, 2018, European journal of medicinal chemistry.

Antihyperglycemic and antihyperlipidemic effect of Uraria crinita water extract in diabetic mice induced by STZ and food

Guang-fa Wang, Jia-jie Zhang, Ying Cao, 2010 .

Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels with natural flavonoid quercetin.

Ying Cao, Jianxin Pang, Pingzheng Zhou, 2020, Biochemical and biophysical research communications.

Identification and characterization of a series of novel HCN channel inhibitors

P. Zhou, Ying Cao, Jianxin Pang, 2018, Acta Pharmacologica Sinica.

DCPIB, an Inhibitor of Volume-Regulated Anion Channels, Distinctly Modulates K2P Channels.

Xiong Cao, K. Yung, L. Kang, 2019, ACS chemical neuroscience.

Characterizations of the Urate Transporter, GLUT9, and Its Potent Inhibitors by Patch-Clamp Technique

Yongmei Li, Ting Wu, Ying Cao, 2020, SLAS discovery : advancing life sciences R & D.

Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia.

Jianjun Chen, Jian Luo, Ting Wu, 2021, European journal of medicinal chemistry.

Antitumor effect of COOH-terminal polypeptide of human TERT is associated with the declined expression of hTERT and NF-κB p65 in HeLa cells.

Jiasheng Chen, Hongwei Li, Xian Wu, 2015, Oncology reports.

Protective effects of S‐carvedilol on doxorubicin‐induced damages to human umbilical vein endothelial cells and rats

Haixin Li, Jiajie Zhang, Shanhe Wan, 2019, Journal of applied toxicology : JAT.

Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents.

Zichao Yang, Jianjun Chen, Hui Liao, 2022, European journal of medicinal chemistry.

Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.

Yongmei Li, Yanqing Jiang, Jian Luo, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection.

Ying Cao, Jianxin Pang, H. Luo, 2022, Pharmacological research.

Inhibition of hyperpolarization‐activated cyclic nucleotide‐gated channels by β‐blocker carvedilol

Ting Wu, Ying Cao, Jianxin Pang, 2018, British journal of pharmacology.

Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels by beta-blocker carvedilol Running title: Inhibition of HCN channels by carvedilol

Ying Cao, Jianxin Pang, Ye-mei Liang, 2018 .

Structural Insights into the Atomistic Mechanisms of Uric Acid Recognition and Translocation of Human Urate Anion Transporter 1

Kutty Selva Nandakumar, Yuan-xin Tian, Yongmei Li, 2020, ACS omega.

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia

Ting Wu, Ying Cao, Jianxin Pang, 2021, Acta Pharmacologica Sinica.

Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.

Yuan-xin Tian, Yongmei Li, Ting Wu, 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation

Ying Cao, Pingzheng Zhou, Linjie Zhang, 2020, Frontiers in Immunology.

Ubiquitin specific peptidase 5 mediates Histidine‐rich protein Hpn induced cell apoptosis in hepatocellular carcinoma through P14‐P53 signaling

H. Kung, Yi Liu, Li Li, 2017, Proteomics.

Identification and characterization of a series of novel HCN channel inhibitors

P. Zhou, Ying Cao, Jianxin Pang, 2018, Acta Pharmacologica Sinica.

Ubiquitin specific peptidase 5 mediates Histidine-rich protein Hpn induced cell apoptosis in hepatocellular carcinoma through P 14P 53 signaling Running title : the functional characterization of HPN in liver cancer

H. Kung, Li Li, M. Lv, 2017 .

HCN Channel as Therapeutic Targets for Heart Failure and Pain.

Ying Cao, Jianxin Pang, Pingzheng Zhou, 2016, Current topics in medicinal chemistry.

effects of hemocoagulase agkistrodon on the coagulation factors and its procoagulant activities

X. Wu, Ying Huang, Ting Wu, 2018 .

Author Correction: CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia

Yong-mei Li, Yuan-xin Tian, Ting Wu, 2022, Acta pharmacologica Sinica.

A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo.

Ying Cao, Pingzheng Zhou, Yuanxing Zhi, 2023, Biochemical pharmacology.

The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function.

Ying Cao, Jianxin Pang, Pingzheng Zhou, 2023, Pharmacological research.